T2 Biosystems Highlights New Article Published In The Lancet, Titled "Changing The Culture Of Blood Culture"
Author: Benzinga Newsdesk | September 23, 2024 08:12am
T2 Biosystems, Inc. (NASDAQ:TTOO) (the "Company"), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today highlighted a recently published article in The Lancet, a world-leading medical journal. The article titled "Changing the Culture of Blood Culture" was authored by Sally Davies, Richard A Marfuggi, Rick A Bright, Steve Brozak, and Michael Osterholm on September 20, 2024.
Posted In: TTOO